Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: INVO Fertility Inc., 3 years.
INVO Fertility Inc.
Director
SenesTech Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
INVO Fertility Inc. July 23, 202692.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 29, 2025 | Cadrenal Therapeutics Inc. | Open-market sale | −9,933 | $6.97 | $69,233 |
| Dec 4, 2025 | INVO Fertility Inc. | Other | −3 | — | — |
| Dec 3, 2025 | INVO Fertility Inc. | Open-market sale | −4 | $1.52 | $6 |
| Nov 14, 2025 | SenesTech Inc. | Open-market sale | −1 | $2.75 | $3 |
| Oct 27, 2025 | Cadrenal Therapeutics Inc. | Open-market sale | −1,800 | $13.99 | $25,182 |
| Oct 24, 2025 | Cadrenal Therapeutics Inc. | Open-market sale | −1,800 | $13.99 | $25,182 |
| Oct 13, 2025 | Cadrenal Therapeutics Inc. | Open-market sale | −1,800 | $14.07 | $25,326 |
| Oct 9, 2025 | Cadrenal Therapeutics Inc. | Open-market sale | −1,693 | $13.99 | $23,685 |
| Oct 6, 2025 | Cadrenal Therapeutics Inc. | Open-market sale | −107 | $13.99 | $1,497 |
| Oct 1, 2025 | Cadrenal Therapeutics Inc. | Open-market sale | −1,700 | $13.99 | $23,783 |
| Sep 29, 2025 | Cadrenal Therapeutics Inc. | Open-market sale | −100 | $14.00 | $1,400 |
| Sep 25, 2025 | Cadrenal Therapeutics Inc. | Open-market sale | −10,900 | $14.05 | $153,145 |
| Sep 24, 2025 | Cadrenal Therapeutics Inc. | Open-market sale | −1,500 | $14.00 | $21,000 |
| Aug 28, 2025 | Cadrenal Therapeutics Inc. | Open-market sale | −400 | $14.00 | $5,600 |
| Aug 27, 2025 | Cadrenal Therapeutics Inc. | Open-market sale | −1,600 | $14.00 | $22,400 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.